Nyxoah (NYXH) Interest & Investment Income (2021 - 2026)
Nyxoah's (NYXH) quarterly Interest & Investment Income came in at $8174.1 in Q1 2026, up 196.38% year-on-year from $2758.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$736.8 million in Q4 2025.
Nyxoah (NYXH) Interest & Investment Income (2021 - 2026) Analysis & Trends
Nyxoah's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $8174.1 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 196.38% year-over-year to $8174.1 in Q1 2026; TTM through Mar 2026 was -$732.3 million, a 124.17% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 20.15% from the prior year.
- Interest & Investment Income advanced to $8174.1 in Q1 2026 per NYXH's latest filing, from -$736.8 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.0 billion in Q4 2024 and bottomed at -$4.7 billion in Q4 2022.
- The 5-year median for Interest & Investment Income is $2.2 million (2024), against an average of $25.7 million.
- Across the five-year window, Interest & Investment Income sank 214.09% in 2022 and surged 37826.11% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at -$4.7 billion in 2022, then soared by 113.32% to $626.2 million in 2023, then jumped by 383.28% to $3.0 billion in 2024, then tumbled by 124.35% to -$736.8 million in 2025, then jumped by 100.0% to $8174.1 in 2026.
- Per Business Quant, the three latest NYXH Interest & Investment Income figures stand at $8174.1 (Q1 2026), -$736.8 million (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 3.91 Mn |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | 8,174.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,174.15 |
| Dec 31, 2025 | -736.84 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 2,758.04 |
| Dec 31, 2024 | 3.03 Bn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 626.20 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 859,161.35 |
| Mar 31, 2023 | 670.84 Mn |
| Dec 31, 2022 | -4.70 Bn |
| Sep 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 4.12 Bn |
| Sep 30, 2021 | 34,199.33 |
| Jun 30, 2021 | 46,966.59 |